Detalles de la búsqueda
1.
Poly (l-lactic acid) bioresorbable scaffolds versus metallic drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 11 randomized trials.
Catheter Cardiovasc Interv
; 96(4): 813-824, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31730255
2.
An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
Catheter Cardiovasc Interv
; 92(2): 302-309, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29027737
3.
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
Lancet
; 388(10059): 2479-2491, 2016 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27806897
4.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Lancet
; 385(9962): 43-54, 2015 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-25230593
5.
A clinical evaluation of the ProNOVA XR polymer-free sirolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions (EURONOVA XR I study).
Indian Heart J
; 65(4): 388-94, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23992999
6.
18F-fluorodeoxyglucose and 18F-sodium fluoride positron emission tomography imaging in assessing early stages of aortic valve degeneration after transcatheter aortic valve implantation.
Pol Arch Intern Med
; 133(12)2023 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966038
7.
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Circulation
; 122(22): 2301-12, 2010 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-21098436
8.
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.
Catheter Cardiovasc Interv
; 78(1): 3-12, 2011 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21413120
9.
Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
Circulation
; 120(15): 1498-504, 2009 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19786634
10.
Polymer-Free vs. Polymer-Coated Drug-Eluting Stents for the Treatment of Coronary Artery Disease: A Meta-Analysis of 16 Randomized Trials.
Cardiovasc Revasc Med
; 21(6): 745-753, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31669109
11.
Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up.
Int J Cardiovasc Imaging
; 34(3): 353-365, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28965166
12.
Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation.
JACC Cardiovasc Interv
; 10(8): 786-795, 2017 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28427595
13.
[Bioresorbable scaffolds in the treatment of coronary artery disease. Expert consensus statement of the Association of Cardiovascular Interventions of the Polish Cardiac Society (ACVI PCS)]. / Zastosowanie rusztowan bioresorbowalnych w leczeniu choroby wiencowej. Stanowisko grupy ekspertów Asocjacji Interwencji Sercowo-Naczyniowych Polskiego Towarzystwa Kardiologicznego (AISN PTK).
Kardiol Pol
; 75(8): 817-835, 2017.
Artículo
en Polaco
| MEDLINE | ID: mdl-28819961
14.
Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.
Circulation
; 112(25): 3876-83, 2005 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-16344384
15.
Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
Circulation
; 111(7): 900-5, 2005 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-15710761
16.
Stenting of unprotected left main coronary artery in patients with low preoperative risk of coronary artery bypass grafting.
Kardiol Pol
; 64(9): 929-36; discussion 937-8, 2006 Sep.
Artículo
en Inglés, Polaco
| MEDLINE | ID: mdl-17054024
17.
A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy.
Cardiovasc Revasc Med
; 17(6): 355-61, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27156201
18.
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
J Am Coll Cardiol
; 67(7): 766-76, 2016 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-26892411
19.
Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions.
Circulation
; 108(7): 788-94, 2003 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-12900339
20.
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions.
EuroIntervention
; 15(8): 685-687, 2019 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30530403